This News From Novo: A Warning for Eli Lilly Shareholders
A GLP-1 drug race is moving from injections to pills, reshaping the landscape for Novo Nordisk and Eli Lilly. Here’s ...
Choosing a retirement plan over a 401k can be beneficial in specific situations. Discover when to make this important choice.
25,535 articlesA GLP-1 drug race is moving from injections to pills, reshaping the landscape for Novo Nordisk and Eli Lilly. Here’s ...
Circle announces a $222 million Arc token presale at a $3 billion FDV, drawing major investors as quarterly revenue g...
Rigetti's Q1 earnings tonight could shape the next move for its stock as Novera shipments and Cepheus milestones feed...
As Uber eyes profitability, a multi-year bull case hinges on margin expansion and stronger bookings. This analysis ou...
Two leading banks issued contrasting views on AMD in a single day, underscoring a broader divide in how investors pri...
A longtime i’m berkshire hathaway investor shifts view on Greg Abel, arguing his disciplined capital allocation and r...
CVS Health posts a robust Q1 driven by Aetna, lifting guidance and reigniting investor optimism. The market now weigh...
Two affordable small-cap stocks under $15 are drawing retail investors' attention as steady packaged foods demand and...
Hedge fund founder Jeffrey Gundlach warns the Fed won’t cut rates at the upcoming meeting amid stubborn inflation, hi...
With winter looming, Ryanair faces higher jet fuel costs. The airline’s CFO says contingency plans are in place as fu...
Guggenheim started coverage on StubHub with a Buy rating and a $12.50 price target, signaling optimism for the live-e...
Wells Fargo and Oppenheimer boosted Marvell targets this week, signaling rising confidence in AI infrastructure deman...